Latest Regulatory Risk News

Page 1 of 35
Aspermont has told ASX that directors John Stark and Graeme McCracken failed to obtain prior approval or notify the company of transactions, leading to late Appendix 3Y notices. ASX raised possible listing rule and Corporations Act breaches, although no penalty or formal finding has been disclosed.
Victor Sage
Victor Sage
17 Nov 2026
DPM Metals reported US$610.1 million of nine-month free cash flow and expects to finish 2026 at the high end of production guidance. But the Vareš mine’s legal foundation remains under review in Bosnia and Herzegovina, creating a sharp contrast between operational momentum and regulatory risk.
Maxwell Dee
Maxwell Dee
13 Nov 2026
New Age Exploration says its participating interests in three permits at the Lammerlaw Gold-Antimony Project have vested in the Crown after the company was removed from New Zealand’s Companies Register. The explorer is seeking reinstatement, but warns it cannot guarantee recovering the project interests.
Maxwell Dee
Maxwell Dee
10 Nov 2026
Eversource Energy narrowed its 2026 recurring earnings guidance after third-quarter GAAP profit fell, while a $26.5 billion investment plan and unresolved regulatory exposures shape the utility’s next phase. The guidance midpoint rose to US$4.66 per share despite lower year-to-date reported earnings.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Helix Resources says it learned of the British Columbia court order setting aside its Gold Basin joint venture on the morning of 14 October, after Canex had published the ruling. The company told ASX it considers the disclosure timely and remains compliant with Listing Rule 3.1.
Maxwell Dee
Maxwell Dee
4 Nov 2026
AMD delivered a record fiscal third quarter as Data Center revenue nearly doubled year over year, pushing total revenue up 45% to US$13.4 billion. The company expects another sharp acceleration in the December quarter, but gaming weakened and customer warrant revaluations distorted GAAP earnings.
Victor Sage
Victor Sage
4 Nov 2026
Entergy delivered a sharp rise in third-quarter earnings, while narrowing its 2026 adjusted EPS guidance and raising its quarterly dividend. Stronger electricity sales, regulatory recovery and construction-related returns drove the result, although rising debt and capital spending remain part of the equation.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Terramin Australia faces an ASX compliance test after lodging a director interest notice seven days after the exchange says it was due. The company must explain the delay and its disclosure controls by 4 November or risk a trading halt or suspension.
Maxwell Dee
Maxwell Dee
2 Nov 2026
Aguia Resources says operations at its Três Estradas phosphate project can continue despite a Brazilian appellate court majority finding its environmental licence invalid. The quarterly report also showed record Santa Barbara gold production, but only A$499,000 in cash and a non-binding US$3 million funding proposal.
Maxwell Dee
Maxwell Dee
30 Oct 2026
GWR Group returned $19.85 million to shareholders during the September quarter, but its balance sheet remains exposed to unresolved Wiluna West liabilities. The company says $12.69 million in State royalties is overdue while the transfer of the tenements to Gold Valley remains incomplete.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Alterity Therapeutics says it has begun operational preparations for a Phase 3 ATH434 trial after FDA minutes confirmed the proposed design and registrational pathway in Multiple System Atrophy. The company ended September with A$41.3 million in cash, while a new US patent extends protection for ATH434 to 2045.
Ada Torres
Ada Torres
30 Oct 2026
Sequoia Financial Group reported a sharp first-quarter revenue decline and pretax loss as authorised representatives left its InterPrac licence. Cash rose to A$11.4 million, but the balance was bolstered by the sale of Centrepoint Alliance shares while ASIC continues to question documentation linked to the InterPrac exit.
Claire Turing
Claire Turing
30 Oct 2026

Browse the archive

Full archive